(Q36845126)

16 August 2017

1 reference

title

ADME pathway approach for pharmacogenetic studies of anti-HIV therapy (English)

1 reference

16 August 2017

Chantal Csajka

2

0 references

Amalio Telenti

series ordinal

3

object named as

Amalio Telenti

1 reference

16 August 2017

Rubin Lubomirov

1

1 reference

16 August 2017

publication date

1 June 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

8

1 reference

16 August 2017

issue

6

1 reference

16 August 2017

page(s)

623-633

1 reference

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Individualising HIV treatment--pharmacogenetics and immunogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Mechanism of indinavir-induced hyperbilirubinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Toward genome-wide SNP genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

A haplotype map of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

TAMAL: an integrated approach to choosing SNPs for genetic studies of human complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

A "silent" polymorphism in the MDR1 gene changes substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Internal ribosome entry sites in cellular mRNAs: mystery of their existence.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Relative impact of nucleotide and copy number variation on gene expression phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

stam--a Bioconductor compliant R package for structured analysis of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Molecular decomposition of complex clinical phenotypes using biologically structured analysis of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Dosage recommendation of phenytoin for patients with epilepsy with different CYP2C9/CYP2C19 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Cluster analysis: an alternative method for covariate selection in population pharmacokinetic modeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Population pharmacokinetics of indinavir in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

A population pharmacokinetic analysis of nelfinavir mesylate in human immunodeficiency virus-infected patients enrolled in a phase III clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: Adult AIDS Clinical Trial Group Study 398.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Pharmacokinetic modeling and simulations of interaction of amprenavir and ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Population pharmacokinetics of enfuvirtide in pediatric patients with human immunodeficiency virus: searching for exposure-response relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Orosomucoid (alpha1-acid glycoprotein) plasma concentration and genetic variants: effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

The comparative toxicogenomics database: a cross-species resource for building chemical-gene interaction networks

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

The genetic association database

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

ALFRED: the ALelle FREquency Database. Update

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

dbSNP: the NCBI database of genetic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

A SNP-centric database for the investigation of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

A new model for the population pharmacokinetics of didanosine in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Understanding human diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

Reply to 'Haplotype block structure of the cytochrome P450 CYP2C gene cluster on chromosome 10'

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.6.623

21 January 2018

Identifiers

DOI

10.2217/14622416.8.6.623

1 reference

16 August 2017

1 reference